# A Study of YM178 in Patients With Symptomatic Overactive Bladder (DRAGON)

> **NCT00337090** · PHASE2 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 1108 (actual)

## Conditions studied

- Overactive Bladder

## Interventions

- **DRUG:** YM178

## Key facts

- **NCT ID:** NCT00337090
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** 2007-03
- **Final completion:** 2007-03
- **Target enrollment:** 1108 (ACTUAL)
- **Last updated:** 2013-07-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00337090

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00337090, "A Study of YM178 in Patients With Symptomatic Overactive Bladder (DRAGON)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00337090. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*